Pearland, TX, United States of America

Shaoyu Yan

USPTO Granted Patents = 1 



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Shaoyu Yan**

Introduction

Shaoyu Yan, an accomplished inventor based in Pearland, Texas, has made significant strides in cancer research through his innovative work. With a focus on therapeutic strategies, Yan has contributed to the understanding and treatment of cancers using TUSC2 therapies. His insights are paving the way for more effective cancer treatments and improved patient responses.

Latest Patents

Shaoyu Yan holds a patent for a method related to TUSC2 therapies. This patent details a method for predicting a subject's response to TUSC2 therapy, specifically by assessing the proportion of apoptotic cancer cells. The invention also outlines a treatment method for those predicted to have a favorable response to TUSC2 therapy. Additionally, it discusses the administration of TUSC2 therapeutics combined with EGFR inhibitors and/or protein kinase inhibitors. The patent further includes the development of kits and reagents to facilitate TUSC2 therapy, showcasing Yan's commitment to enhancing cancer treatment modalities.

Career Highlights

Currently, Yan is associated with the University of Texas System, where he engages in groundbreaking research. His tenure at this prestigious institution has allowed him to collaborate with leading minds in the field, further enriching his contributions to cancer therapy.

Collaborations

Throughout his career, Shaoyu Yan has collaborated with notable colleagues such as Jack A. Roth and David J. Stewart. These partnerships have played a critical role in advancing his research and patent developments, emphasizing the importance of teamwork in scientific innovation.

Conclusion

Shaoyu Yan is an exemplary figure in the realm of cancer research and therapy. Through his innovative TUSC2 therapies and his commitment to exploring new treatment methods, he is shaping the future of cancer treatment. His contributions reflect the vital intersection of research and practical application, ultimately aiming to improve patient outcomes in cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…